Dr Lal Pathlabs. shareholding pattern

LALPATHLAB

1402.3

6.30 (-0.45%)
Last updated on 20 Feb, 2026 | 15:47 IST
alert_iconwatchlist_icon
BUYSELL
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Dr Lal Pathlabs. Shareholding Pattern

  • 2018-19
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2019-20
Total Promoters
Segment
Percent

Total Promoters

56.91%

Mutual Fund

6.75%

Insurance

0%

Foreign Institutional Investors

16.71%

Domestic Institutional Investors

1.63%

Retail

18%

Others

0%

Total Promoters
MAR '18
57.42%
JUN '18
57.41%
SEP '18
57.41%
DEC '18
56.91%

Summary

For Year 2025-26, Dr Lal Pathlabs. reports the following shareholding: Total Promoters at 53.21%, Mutual Fund at 16.84%, Insurance at 2.18%, Foreign Institutional Investors at 20.29%, Domestic Institutional Investors at 0.05%, and Retail at 7.43%. This breakdown provides a quick snapshot of ownership distribution for Dr Lal Pathlabs. in 2025-26.

Dr Lal Pathlabs. FAQs

As of 02-2026, the promoter shareholding in Dr Lal Pathlabs. stands at 53.21% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Dr Lal Pathlabs. is 20.29% and 0.05% respectively.

The retail shareholding of the Dr Lal Pathlabs. is 7.43%.

Changes in shareholding patterns of Dr Lal Pathlabs. can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Dr Lal Pathlabs. are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost